TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26734954

Group type: EXPERIMENTAL
Intervention: Red wine (230 ml/day for women, 300 ml/day for men)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Water
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dealcoholized red wine (DRW)
Number of subjects: 24
Study: 24473592

Group type: EXPERIMENTAL
Intervention: Child Development Accounts (CDAs) with additional financial incentives and information
Number of subjects: 2704

Group type: EXPERIMENTAL
Intervention: Child Development Accounts (CDAs) for low-income households
Number of subjects: 2704

Group type: COMPARATOR
Intervention: Control group (no CDAs)
Number of subjects: 2704
Study: 22848584

Group type: EXPERIMENTAL
Intervention: Psyllium supplementation (6 g/day for 6 weeks)
Number of subjects: 47
Study: 20704623

Group type: EXPERIMENTAL
Intervention: Pimecrolimus
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 17157066

Group type: EXPERIMENTAL
Intervention: Atrial overdrive pacing (O)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Pacemaker rate set at 40‐50 beats per minutes (N)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 15
Study: 16045013

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/d) + Benazepril (10 mg/d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Benazepril (10 mg/d)
Number of subjects: 60
Study: 12815796

Group type: EXPERIMENTAL
Intervention: Electrogastrography (EGG) recording after a meal
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Bradygastria (group I)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Tachygastria (group II)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 67
Study: 10408721

Group type: EXPERIMENTAL
Intervention: Photopheresis
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 16
Study: 7480098

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Quinidine (200 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of nifedipine (20 mg) and quinidine (200 mg)
Number of subjects: 12
Study: 2110817

Group type: EXPERIMENTAL
Intervention: Non-sedative antihistamine terfenadine (60 mg b.i.d.)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Sedative antihistamine clemastine (2 mg b.i.d.)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 117755

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Milk feeding
Number of subjects: 34
Study: 29349922

Group type: EXPERIMENTAL
Intervention: Breast milk intake at 9-10 months of age (mean 752 g/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proportion of total energy intake from breast milk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Breast milk intake and percent of total energy intake from breast milk
Number of subjects: 0
Study: 27225338

Group type: EXPERIMENTAL
Intervention: 60 mg/kg magnesium sulfate via cardioplegic solution
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 80 mg/kg magnesium sulfate via cardioplegic solution
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 100 mg/kg magnesium sulfate via cardioplegic solution
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 80 mg/kg and 100 mg/kg magnesium sulfate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 100 mg/kg magnesium sulfate
Number of subjects: 120
Study: 25342641

Group type: EXPERIMENTAL
Intervention: Assertive Community Treatment (ACT)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Community Treatment Order
Number of subjects: 251

Group type: COMPARATOR
Intervention: Usual care by CMHTs
Number of subjects: 251
Study: 23912367

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 40
Study: 20403667

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN) group, initiated between 3 and 6 hours after burn
Number of subjects: 688

Group type: COMPARATOR
Intervention: Late enteral nutrition (LEN) group, received only intravenous resuscitation in the first 48 hours
Number of subjects: 688
Study: 18616780

Group type: EXPERIMENTAL
Intervention: Triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Hydroquinone 4% cream
Number of subjects: 252
Study: 16895631

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 287

Group type: COMPARATOR
Intervention: Control (no metformin)
Number of subjects: 287
Study: 11453911

Group type: EXPERIMENTAL
Intervention: Long-pulsed tunable dye laser (LPTDL, 585 nm; 5-mm spot size; 11-20 J cm(‐2) fluence)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Flashlamp-pumped dye laser (FPDL, 585 nm; 7-mm spot size; 5.75-7.0 J cm(‐2) fluence)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Both lasers at 585 nm
Number of subjects: 62
Study: 10211066

Group type: EXPERIMENTAL
Intervention: Digital screening system with C-arm
Number of subjects: 45

Group type: COMPARATOR
Intervention: Analogue fluoroscopic unit and standard film‐screen radiography
Number of subjects: 45
Study: 7519032

Group type: EXPERIMENTAL
Intervention: 1,24(OH)2D3 ointment (tacalcitol; 4 micrograms/g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2928741

Group type: EXPERIMENTAL
Intervention: Clonidine 0.075 mg twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1410124

Group type: EXPERIMENTAL
Intervention: Alcohol (high dose: 1.1 ml. ethanol/kilogram body weight)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 648938

Group type: EXPERIMENTAL
Intervention: Cimetidine treatment for 12 weeks
Number of subjects: 16
Study: 31419309

Group type: EXPERIMENTAL
Intervention: Histamine 1% applied onto the volar forearm
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Functional MRI
Number of subjects: 30

Group type: COMPARATOR
Intervention: Histamine skin prick model
Number of subjects: 30
Study: 27569403

Group type: EXPERIMENTAL
Intervention: Printed Post-it® note
Number of subjects: 611

Group type: COMPARATOR
Intervention: Control (without Post-it® note)
Number of subjects: 611
Study: 26319612

Group type: EXPERIMENTAL
Intervention: biofortified gari (1 mg β‐carotene)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: red palm oil-fortified gari (1 mg β‐carotene)
Number of subjects: 8

Group type: COMPARATOR
Intervention: unfortified gari (0.3 mg retinyl palmitate reference dose)
Number of subjects: 8
Study: 24303604

Group type: EXPERIMENTAL
Intervention: Higher mean arterial pressure (MAP) during cardiopulmonary bypass (CPB); MAP attained 77.7 ± 7.1 mmHg
Number of subjects: 248

Group type: COMPARATOR
Intervention: Lower mean arterial pressure (MAP) during cardiopulmonary bypass (CPB); MAP attained 56.7 ± 5.0 mmHg
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Pharmacologic protocol for maintaining higher MAP
Number of subjects: 248
Study: 20644943

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg q.d.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 100 mg q.d.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Combination of ASA and clopidogrel
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 120
Study: 19269773

Group type: EXPERIMENTAL
Intervention: Topiramate (up to 300mg/day)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Naltrexone (50mg/day)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study: 17589944

Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy (gemcitabine and radiation dose 50.4 Gy) before surgery
Number of subjects: 47

Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Chemoradiation therapy (gemcitabine and radiation dose 50.4 Gy) before surgery in ductal adenocarcinoma
Number of subjects: 47

Group type: COMPARATOR
Intervention: Surgery only in ductal adenocarcinoma
Number of subjects: 47
Study: 15140780

Group type: EXPERIMENTAL
Intervention: PVAC (50 micro g)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: PVAC
Number of subjects: 36
Study: 12407061

Group type: EXPERIMENTAL
Intervention: Heparin and aspirin (group 1)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Heparin or aspirin (group 2)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Aspirin alone (group 3)
Number of subjects: 79
Study: 9821562

Group type: EXPERIMENTAL
Intervention: Schizophrenic patients
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 24
Study: 7859654

Group type: EXPERIMENTAL
Intervention: Chlorhexidine washed (non-pregnant)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Chlorhexidine washed (pregnant)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Saline washed (pregnant)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Not washed (pregnant)
Number of subjects: 160
Study: 2675439

Group type: EXPERIMENTAL
Intervention: 75 mg chlorophyll tablets thrice daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 1089971

Group type: EXPERIMENTAL
Intervention: Synthetic luteinizing hormone-releasing hormone (LH-RH) 50 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synthetic luteinizing hormone-releasing hormone (LH-RH) 100 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synthetic luteinizing hormone-releasing hormone (LH-RH) 1 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synthetic luteinizing hormone-releasing hormone (LH-RH) 0.25 to 4 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two injections of LH-RH 90 min apart
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two injections of LH-RH 30 or 45 min apart
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower doses of LH-RH (not specified)
Number of subjects: 0
Study: 31651959

Group type: EXPERIMENTAL
Intervention: Increased levels of three amino acids (asparagine, homoarginine, tryptophan) and docosatrienoic acid
Number of subjects: 2298

Group type: EXPERIMENTAL
Intervention: Increased levels of C4-OH-carnitine, hexadecanedioate, N2,N2-dimethylguanosine, N4-acetylcytidine
Number of subjects: 2298

Group type: EXPERIMENTAL
Intervention: Metabolite score comprising 17 metabolites
Number of subjects: 2298

Group type: EXPERIMENTAL
Intervention: Metabolite score
Number of subjects: 2298
Study: 30967128

Group type: COMPARATOR
Intervention: Retro walking
Number of subjects: 68

Group type: COMPARATOR
Intervention: Forward walking
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 28079814

Group type: EXPERIMENTAL
Intervention: Lens-decentration group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ROC curve analysis
Number of subjects: 60
Study: 26319652

Group type: EXPERIMENTAL
Intervention: Physiotherapy program (overall stretching, specific stretches, Kegel exercises, jogging, and relaxation exercises) for three months
Number of subjects: 160

Group type: COMPARATOR
Intervention: No intervention program
Number of subjects: 160
Study: 23368826

Group type: EXPERIMENTAL
Intervention: High-fat meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 12
Study: 20579847

Group type: EXPERIMENTAL
Intervention: Fructo-oligosaccharides (FOS) 10 g/d
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Post-FOS period
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (3 mL of fructose syrup)
Number of subjects: 10
Study: 19279365

Group type: EXPERIMENTAL
Intervention: CDC model early stimulation therapy (home-based)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Routine postnatal check-up as per hospital practice
Number of subjects: 800
Study: 18022209

Group type: EXPERIMENTAL
Intervention: Achromatic COCE with contours modulated along the luminance axis of the DKL color space
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chromatic COCE with contours modulated along the L‐M or S‐(L+M) axis
Number of subjects: 0
Study: 15033892

Group type: EXPERIMENTAL
Intervention: Fentanyl 2 microg ml(‐1) in bupivacaine 0.1%
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Fentanyl 5 microg ml(‐1) in bupivacaine 0.1%
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Fentanyl 10 microg ml(‐1) in bupivacaine 0.1%
Number of subjects: 99
Study: 11463988

Group type: EXPERIMENTAL
Intervention: Filgrastim (r-metHuG-CSF)
Number of subjects: 0
Study: 9587125

Group type: EXPERIMENTAL
Intervention: Brain surgery
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: External beam radiation therapy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Radiation therapy for metastatic disease
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Chemotherapy with doxorubicin-containing regimens
Number of subjects: 34
Study: 7522747

Group type: EXPERIMENTAL
Intervention: Hyperthermia treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study: 2970122

Group type: EXPERIMENTAL
Intervention: Artificial intelligence techniques
Number of subjects: 200

Group type: COMPARATOR
Intervention: Clinician diagnosis
Number of subjects: 200
Study: 29144799

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel total thyroidectomy
Number of subjects: 269

Group type: COMPARATOR
Intervention: Classic total thyroidectomy
Number of subjects: 269
Study: 28077826

Group type: EXPERIMENTAL
Intervention: Customized birth control program (4 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 42
Study: 24921253

Group type: EXPERIMENTAL
Intervention: WASH indicators used in classification and regression trees (C&RT) analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WASH indicators used in conditional inference trees (CIT) analysis
Number of subjects: 0
Study: 22550196

Group type: EXPERIMENTAL
Intervention: Fish oil capsules (four 1-g capsules/d)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 20819892

Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted H5N1 vaccine (7.5 μg/dose)
Number of subjects: 472

Group type: COMPARATOR
Intervention: MF59-adjuvanted trivalent seasonal influenza control vaccine (15 μg/dose for each antigen)
Number of subjects: 472
Study: 18165395

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 100 mg/d
Number of subjects: 707

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 707
Study: 15853463

Group type: EXPERIMENTAL
Intervention: WAD patients
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: MRI lesions to the alar ligaments
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: MRI lesions to the transverse ligament and posterior atlanto-occipital membrane
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Increasing number of abnormal (grade 2-3) structures
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (30 persons)
Number of subjects: 92
Study: 12913696

Group type: EXPERIMENTAL
Intervention: Intravesical electromotive mitomycin C (40 mg with 20 mA electric current for 30 minutes)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Passive transport mitomycin C (40 mg with a dwell time of 60 minutes)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Bacillus Calmette‐Guerin (81 mg with a dwell time of 120 minutes)
Number of subjects: 108
Study: 10351971

Group type: EXPERIMENTAL
Intervention: Pacing from the posterior wall (PW) or coronary sinus ostium (CSO)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Pacing from the lateral wall (LW)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Pacing from the posterior wall (PW)
Number of subjects: 22
Study: 7725890

Group type: EXPERIMENTAL
Intervention: Diclofenac 1.0 mg.kg‐1 i.v. after general anaesthesia induction, before surgical incision, and four hours later the same dose was given i.m.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Ketoprofen 1.35 mg.kg‐1 i.v. and i.m.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline control (comparable volume i.v. and i.m.)
Number of subjects: 90
Study: 2029413

Group type: EXPERIMENTAL
Intervention: External beam radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radical prostatectomy
Number of subjects: 0
Study: 7028759

Group type: EXPERIMENTAL
Intervention: Multi-drug chemotherapy with local radiotherapy (5-FU and local radiotherapy to a dose of 4600 rad, then Methyl-CCNU)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Multi-drug chemotherapy without radiotherapy (5-FU and Methyl-CCNU)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Multi-drug chemotherapy with local radiotherapy
Number of subjects: 59

Group type: COMPARATOR
Intervention: Multi-drug chemotherapy without radiotherapy
Number of subjects: 59
Study: 30998046

Group type: EXPERIMENTAL
Intervention: Long-term psychoanalytic psychotherapy (LTPP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 29127417

Group type: EXPERIMENTAL
Intervention: Xueshuan Xinmai tablets (XXMT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 27507715

Group type: EXPERIMENTAL
Intervention: Single-Incision Laparoscopic Colectomy (SILC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Multiport Laparoscopic Colectomy (MPLC)
Number of subjects: 200
Study: 24992753

Group type: EXPERIMENTAL
Intervention: Acupuncture at hour-prescriptive points (9 to 11 AM)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Acupuncture at any time beyond 9 to 11 AM (control group)
Number of subjects: 72
Study: 22691451

Group type: EXPERIMENTAL
Intervention: SCORES intervention (multi-component PA and FMS intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SCORES intervention
Number of subjects: 0
Study: 20826623

Group type: EXPERIMENTAL
Intervention: Unsaturated fat diet
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Protein diet
Number of subjects: 162

Group type: COMPARATOR
Intervention: Self-selected diets
Number of subjects: 162
Study: 18394772

Group type: COMPARATOR
Intervention: Nifedipine slow-release tablets (60 mg/d)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Nifedipine gastrointestinal therapeutic system (GITS) tablets (90 mg/d)
Number of subjects: 14
Study: 15744147

Group type: EXPERIMENTAL
Intervention: Non-viral IL-2 gene therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control plasmid in cationic lipid formulation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Methotrexate chemotherapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cisplatin in combination with IL-2 gene therapy
Number of subjects: 10
Study: 12866363

Group type: EXPERIMENTAL
Intervention: DHEP lecithin
Number of subjects: 100

Group type: COMPARATOR
Intervention: DHEP gel
Number of subjects: 100
Study: 10394695

Group type: EXPERIMENTAL
Intervention: Group health education workshop for two days in the first and second years
Number of subjects: 243

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 243
Study: 9082374

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg/d)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Atenolol (50 mg/d)
Number of subjects: 147
Study: 8453465

Group type: EXPERIMENTAL
Intervention: Acallosal subjects
Number of subjects: 24

Group type: COMPARATOR
Intervention: IQ-matched controls
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Manual pointing response mode
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral response mode
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Left and right field stimulus presentation
Number of subjects: 24
Study: 3021502

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29730489

Group type: EXPERIMENTAL
Intervention: diet-only
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: exercise-only
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: combined diet and exercise
Number of subjects: 323
Study: 27681572

Group type: EXPERIMENTAL
Intervention: TAU plus four 2.5-h weekly sessions of theory-based lifestyle structured group education, maintenance contact every 2 weeks, and 'booster' sessions every 3 months.
Number of subjects: 396
Study: 24243918

Group type: EXPERIMENTAL
Intervention: Excitatory rTMS (10 Hz)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Inhibitory rTMS (1 Hz)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 5
Study: 24486422

Group type: EXPERIMENTAL
Intervention: 20mg of methylphenidate (MPH)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 22147473

Group type: COMPARATOR
Intervention: SFC (steam-flaked corn) diet with 0% WDG (wet distillers grain plus solubles)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: SFC with increasing WDG concentrations (15, 30, 45, 60% DM basis)
Number of subjects: 600

Group type: COMPARATOR
Intervention: DRC (dry-rolled corn) diet without WDG
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: SFC diet
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Increasing WDG concentrations
Number of subjects: 600
Study: 19214892

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Extraductal endoscopic ultrasonography (EDUS)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Comparison of EUS vs EDUS
Number of subjects: 155
Study: 17445284

Group type: EXPERIMENTAL
Intervention: Total cholesterol (all treatment groups)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: HDL-C (all treatment groups)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: TAG (all treatment groups)
Number of subjects: 155
Study: 15883577

Group type: EXPERIMENTAL
Intervention: Medication-assisted manipulation (MAM)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Spinal manipulation therapy (SMT)
Number of subjects: 68
Study: 12517610

Group type: EXPERIMENTAL
Intervention: Endonasal endoscopic surgery
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sublabial transsphenoidal microsurgery
Number of subjects: 44
Study: 9791356

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hydrocellular dressing
Number of subjects: 100